Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis

Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis

Abstract Background Patients with autoimmune and immune-mediated diseases (AI-IMD) are at greater risk of COVID-19 infection; therefore, they should be prioritized in vaccination programs. However, there are concerns regarding the safety of COVID-19 vaccines in terms of disease relapse, flare, or ex...

Full description

Bibliographic Details
Main Authors: Mahya Shabani, Parnian Shobeiri, Shadi Nouri, Zahra Moradi, Robel Assefa Amenu, Mohammad-Mehdi Mehrabi Nejad, Nima Rezaei
Format: Article
Language:English
Published: BMC 2024-01-01
Series:European Journal of Medical Research
Subjects:
Autoimmune disease
mRNA
Vector-based vaccine
COVID-19
Vaccine
Online Access:https://doi.org/10.1186/s40001-024-01639-4

Internet

https://doi.org/10.1186/s40001-024-01639-4

Similar Items